开云app官网登录入口网页版-官方正版

[GetPortalCommentsPageByObjectIdResponse(id=2160645, encodeId=6e462160645b6, content=找了一天作者协议，还是没找到😓, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e99e8999472, createdName=ms7000001592099357, createdTime=Mon Oct 02 19:40:44 CST 2023, time=2023-10-02, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2139436, encodeId=836e213943670, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：投的meta，审稿非常快，编辑光速送审，5月7号送审，24号给了major revision，两个审稿人，一个很客气，说文章写的很好没有意见，另一个让补充一些方法学上的细节。好好修改感觉希望挺大，加油。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9e446571671, createdName=ms4000000706495698, createdTime=Sat May 27 22:31:56 CST 2023, time=2023-05-27, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=921068, encodeId=d6e692106875, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：1.8号投稿，29号小修回来，这个杂志还挺友善！我的第一篇英文顺利的不敢相信, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=191, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1ca92518561, createdName=124d4ad8m98暂无昵称, createdTime=Fri Jan 29 16:00:11 CST 2021, time=2021-01-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2102408, encodeId=5abd2102408f9, content=想问一下 author consent 怎么写呀没有在官网上找到模板, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/ibHKLVerWUC6yA015Ulu0FMP25mVc8zpF2pTqqibxmn0mD6oiblRHRJicmK18IZjr8cP1ZwLAclpASA2ib1iboqnBjnQ/132, createdBy=deed2538978, createdName=2668, createdTime=Thu Nov 24 14:28:22 CST 2022, time=2022-11-24, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=904198, encodeId=2d8390419824, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：内分泌 经验分享：感觉这个杂志还蛮友好的，9月初投的，20天后修回，大修俩月，提交后7天内接收，，，速度很快了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=223, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cae35440569, createdName=雨的印记373, createdTime=Wed Dec 02 10:47:43 CST 2020, time=2020-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2107104, encodeId=2894210e104f8, content=这篇杂志怎么选择OA啊，投稿系统里好像没找到, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230207/b5a05d43ae3d4607be87681842f23191/2d0014efa1884564aaf3c599d3ce0930.jpg, createdBy=3e988123090, createdName=ms8000000110142808, createdTime=Thu Dec 22 21:47:52 CST 2022, time=2022-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1237426, encodeId=ae9d123e4263a, content=已经decision in process一个半月了，还没结果，邮件也不回, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ed76523841, createdName=ms8000000952576819, createdTime=Mon Aug 08 19:01:25 CST 2022, time=2022-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=545734, encodeId=5595545e34dd, content=投的meta，审稿很慢，5个多月，还是被拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=424, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7cb81934323, createdName=zxyy1386, createdTime=Mon Aug 21 15:57:00 CST 2017, time=2017-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092943, encodeId=fcd3109294324, content=结果中的重要文献是在结果体现，还是在引言中描述？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092944, encodeId=a7e7109294482, content=方法的撰写顺序/逻辑顺序是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=)]

2023-10-02 ms7000001592099357 来自安徽省

找了一天作者协议，还是没找到😓

86 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2160645, encodeId=6e462160645b6, content=找了一天作者协议，还是没找到😓, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e99e8999472, createdName=ms7000001592099357, createdTime=Mon Oct 02 19:40:44 CST 2023, time=2023-10-02, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2139436, encodeId=836e213943670, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：投的meta，审稿非常快，编辑光速送审，5月7号送审，24号给了major revision，两个审稿人，一个很客气，说文章写的很好没有意见，另一个让补充一些方法学上的细节。好好修改感觉希望挺大，加油。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9e446571671, createdName=ms4000000706495698, createdTime=Sat May 27 22:31:56 CST 2023, time=2023-05-27, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=921068, encodeId=d6e692106875, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：1.8号投稿，29号小修回来，这个杂志还挺友善！我的第一篇英文顺利的不敢相信, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=191, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1ca92518561, createdName=124d4ad8m98暂无昵称, createdTime=Fri Jan 29 16:00:11 CST 2021, time=2021-01-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2102408, encodeId=5abd2102408f9, content=想问一下 author consent 怎么写呀没有在官网上找到模板, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/ibHKLVerWUC6yA015Ulu0FMP25mVc8zpF2pTqqibxmn0mD6oiblRHRJicmK18IZjr8cP1ZwLAclpASA2ib1iboqnBjnQ/132, createdBy=deed2538978, createdName=2668, createdTime=Thu Nov 24 14:28:22 CST 2022, time=2022-11-24, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=904198, encodeId=2d8390419824, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：内分泌 经验分享：感觉这个杂志还蛮友好的，9月初投的，20天后修回，大修俩月，提交后7天内接收，，，速度很快了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=223, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cae35440569, createdName=雨的印记373, createdTime=Wed Dec 02 10:47:43 CST 2020, time=2020-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2107104, encodeId=2894210e104f8, content=这篇杂志怎么选择OA啊，投稿系统里好像没找到, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230207/b5a05d43ae3d4607be87681842f23191/2d0014efa1884564aaf3c599d3ce0930.jpg, createdBy=3e988123090, createdName=ms8000000110142808, createdTime=Thu Dec 22 21:47:52 CST 2022, time=2022-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1237426, encodeId=ae9d123e4263a, content=已经decision in process一个半月了，还没结果，邮件也不回, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ed76523841, createdName=ms8000000952576819, createdTime=Mon Aug 08 19:01:25 CST 2022, time=2022-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=545734, encodeId=5595545e34dd, content=投的meta，审稿很慢，5个多月，还是被拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=424, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7cb81934323, createdName=zxyy1386, createdTime=Mon Aug 21 15:57:00 CST 2017, time=2017-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092943, encodeId=fcd3109294324, content=结果中的重要文献是在结果体现，还是在引言中描述？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092944, encodeId=a7e7109294482, content=方法的撰写顺序/逻辑顺序是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=)]

2023-05-27 ms4000000706495698 来自上海

审稿速度:1.0 | 投稿命中率:75.0
经验分享：投的meta，审稿非常快，编辑光速送审，5月7号送审，24号给了major revision，两个审稿人，一个很客气，说文章写的很好没有意见，另一个让补充一些方法学上的细节。好好修改感觉希望挺大，加油。

87 6

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=2160645, encodeId=6e462160645b6, content=找了一天作者协议，还是没找到😓, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e99e8999472, createdName=ms7000001592099357, createdTime=Mon Oct 02 19:40:44 CST 2023, time=2023-10-02, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2139436, encodeId=836e213943670, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：投的meta，审稿非常快，编辑光速送审，5月7号送审，24号给了major revision，两个审稿人，一个很客气，说文章写的很好没有意见，另一个让补充一些方法学上的细节。好好修改感觉希望挺大，加油。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9e446571671, createdName=ms4000000706495698, createdTime=Sat May 27 22:31:56 CST 2023, time=2023-05-27, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=921068, encodeId=d6e692106875, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：1.8号投稿，29号小修回来，这个杂志还挺友善！我的第一篇英文顺利的不敢相信, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=191, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1ca92518561, createdName=124d4ad8m98暂无昵称, createdTime=Fri Jan 29 16:00:11 CST 2021, time=2021-01-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2102408, encodeId=5abd2102408f9, content=想问一下 author consent 怎么写呀没有在官网上找到模板, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/ibHKLVerWUC6yA015Ulu0FMP25mVc8zpF2pTqqibxmn0mD6oiblRHRJicmK18IZjr8cP1ZwLAclpASA2ib1iboqnBjnQ/132, createdBy=deed2538978, createdName=2668, createdTime=Thu Nov 24 14:28:22 CST 2022, time=2022-11-24, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=904198, encodeId=2d8390419824, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：内分泌 经验分享：感觉这个杂志还蛮友好的，9月初投的，20天后修回，大修俩月，提交后7天内接收，，，速度很快了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=223, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cae35440569, createdName=雨的印记373, createdTime=Wed Dec 02 10:47:43 CST 2020, time=2020-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2107104, encodeId=2894210e104f8, content=这篇杂志怎么选择OA啊，投稿系统里好像没找到, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230207/b5a05d43ae3d4607be87681842f23191/2d0014efa1884564aaf3c599d3ce0930.jpg, createdBy=3e988123090, createdName=ms8000000110142808, createdTime=Thu Dec 22 21:47:52 CST 2022, time=2022-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1237426, encodeId=ae9d123e4263a, content=已经decision in process一个半月了，还没结果，邮件也不回, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ed76523841, createdName=ms8000000952576819, createdTime=Mon Aug 08 19:01:25 CST 2022, time=2022-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=545734, encodeId=5595545e34dd, content=投的meta，审稿很慢，5个多月，还是被拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=424, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7cb81934323, createdName=zxyy1386, createdTime=Mon Aug 21 15:57:00 CST 2017, time=2017-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092943, encodeId=fcd3109294324, content=结果中的重要文献是在结果体现，还是在引言中描述？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092944, encodeId=a7e7109294482, content=方法的撰写顺序/逻辑顺序是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=)]

2021-01-29 124d4ad8m98暂无昵称

审稿速度:2.0 | 投稿命中率:75.0
经验分享：1.8号投稿，29号小修回来，这个杂志还挺友善！我的第一篇英文顺利的不敢相信

191 12

展开12条回复

[GetPortalCommentsPageByObjectIdResponse(id=2160645, encodeId=6e462160645b6, content=找了一天作者协议，还是没找到😓, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e99e8999472, createdName=ms7000001592099357, createdTime=Mon Oct 02 19:40:44 CST 2023, time=2023-10-02, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2139436, encodeId=836e213943670, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：投的meta，审稿非常快，编辑光速送审，5月7号送审，24号给了major revision，两个审稿人，一个很客气，说文章写的很好没有意见，另一个让补充一些方法学上的细节。好好修改感觉希望挺大，加油。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9e446571671, createdName=ms4000000706495698, createdTime=Sat May 27 22:31:56 CST 2023, time=2023-05-27, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=921068, encodeId=d6e692106875, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：1.8号投稿，29号小修回来，这个杂志还挺友善！我的第一篇英文顺利的不敢相信, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=191, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1ca92518561, createdName=124d4ad8m98暂无昵称, createdTime=Fri Jan 29 16:00:11 CST 2021, time=2021-01-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2102408, encodeId=5abd2102408f9, content=想问一下 author consent 怎么写呀没有在官网上找到模板, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/ibHKLVerWUC6yA015Ulu0FMP25mVc8zpF2pTqqibxmn0mD6oiblRHRJicmK18IZjr8cP1ZwLAclpASA2ib1iboqnBjnQ/132, createdBy=deed2538978, createdName=2668, createdTime=Thu Nov 24 14:28:22 CST 2022, time=2022-11-24, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=904198, encodeId=2d8390419824, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：内分泌 经验分享：感觉这个杂志还蛮友好的，9月初投的，20天后修回，大修俩月，提交后7天内接收，，，速度很快了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=223, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cae35440569, createdName=雨的印记373, createdTime=Wed Dec 02 10:47:43 CST 2020, time=2020-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2107104, encodeId=2894210e104f8, content=这篇杂志怎么选择OA啊，投稿系统里好像没找到, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230207/b5a05d43ae3d4607be87681842f23191/2d0014efa1884564aaf3c599d3ce0930.jpg, createdBy=3e988123090, createdName=ms8000000110142808, createdTime=Thu Dec 22 21:47:52 CST 2022, time=2022-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1237426, encodeId=ae9d123e4263a, content=已经decision in process一个半月了，还没结果，邮件也不回, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ed76523841, createdName=ms8000000952576819, createdTime=Mon Aug 08 19:01:25 CST 2022, time=2022-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=545734, encodeId=5595545e34dd, content=投的meta，审稿很慢，5个多月，还是被拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=424, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7cb81934323, createdName=zxyy1386, createdTime=Mon Aug 21 15:57:00 CST 2017, time=2017-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092943, encodeId=fcd3109294324, content=结果中的重要文献是在结果体现，还是在引言中描述？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092944, encodeId=a7e7109294482, content=方法的撰写顺序/逻辑顺序是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=)]

2022-11-24 2668 来自江苏省

想问一下 author consent 怎么写呀没有在官网上找到模板

93 9

展开9条回复

[GetPortalCommentsPageByObjectIdResponse(id=2160645, encodeId=6e462160645b6, content=找了一天作者协议，还是没找到😓, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e99e8999472, createdName=ms7000001592099357, createdTime=Mon Oct 02 19:40:44 CST 2023, time=2023-10-02, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2139436, encodeId=836e213943670, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：投的meta，审稿非常快，编辑光速送审，5月7号送审，24号给了major revision，两个审稿人，一个很客气，说文章写的很好没有意见，另一个让补充一些方法学上的细节。好好修改感觉希望挺大，加油。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9e446571671, createdName=ms4000000706495698, createdTime=Sat May 27 22:31:56 CST 2023, time=2023-05-27, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=921068, encodeId=d6e692106875, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：1.8号投稿，29号小修回来，这个杂志还挺友善！我的第一篇英文顺利的不敢相信, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=191, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1ca92518561, createdName=124d4ad8m98暂无昵称, createdTime=Fri Jan 29 16:00:11 CST 2021, time=2021-01-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2102408, encodeId=5abd2102408f9, content=想问一下 author consent 怎么写呀没有在官网上找到模板, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/ibHKLVerWUC6yA015Ulu0FMP25mVc8zpF2pTqqibxmn0mD6oiblRHRJicmK18IZjr8cP1ZwLAclpASA2ib1iboqnBjnQ/132, createdBy=deed2538978, createdName=2668, createdTime=Thu Nov 24 14:28:22 CST 2022, time=2022-11-24, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=904198, encodeId=2d8390419824, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：内分泌 经验分享：感觉这个杂志还蛮友好的，9月初投的，20天后修回，大修俩月，提交后7天内接收，，，速度很快了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=223, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cae35440569, createdName=雨的印记373, createdTime=Wed Dec 02 10:47:43 CST 2020, time=2020-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2107104, encodeId=2894210e104f8, content=这篇杂志怎么选择OA啊，投稿系统里好像没找到, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230207/b5a05d43ae3d4607be87681842f23191/2d0014efa1884564aaf3c599d3ce0930.jpg, createdBy=3e988123090, createdName=ms8000000110142808, createdTime=Thu Dec 22 21:47:52 CST 2022, time=2022-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1237426, encodeId=ae9d123e4263a, content=已经decision in process一个半月了，还没结果，邮件也不回, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ed76523841, createdName=ms8000000952576819, createdTime=Mon Aug 08 19:01:25 CST 2022, time=2022-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=545734, encodeId=5595545e34dd, content=投的meta，审稿很慢，5个多月，还是被拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=424, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7cb81934323, createdName=zxyy1386, createdTime=Mon Aug 21 15:57:00 CST 2017, time=2017-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092943, encodeId=fcd3109294324, content=结果中的重要文献是在结果体现，还是在引言中描述？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092944, encodeId=a7e7109294482, content=方法的撰写顺序/逻辑顺序是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=)]

2020-12-02 雨的印记373

审稿速度:1.0 | 投稿命中率:75.0
偏重的研究方向：内分泌
经验分享：感觉这个杂志还蛮友好的，9月初投的，20天后修回，大修俩月，提交后7天内接收，，，速度很快了

223 8

展开8条回复

[GetPortalCommentsPageByObjectIdResponse(id=2160645, encodeId=6e462160645b6, content=找了一天作者协议，还是没找到😓, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e99e8999472, createdName=ms7000001592099357, createdTime=Mon Oct 02 19:40:44 CST 2023, time=2023-10-02, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2139436, encodeId=836e213943670, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：投的meta，审稿非常快，编辑光速送审，5月7号送审，24号给了major revision，两个审稿人，一个很客气，说文章写的很好没有意见，另一个让补充一些方法学上的细节。好好修改感觉希望挺大，加油。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9e446571671, createdName=ms4000000706495698, createdTime=Sat May 27 22:31:56 CST 2023, time=2023-05-27, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=921068, encodeId=d6e692106875, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：1.8号投稿，29号小修回来，这个杂志还挺友善！我的第一篇英文顺利的不敢相信, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=191, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1ca92518561, createdName=124d4ad8m98暂无昵称, createdTime=Fri Jan 29 16:00:11 CST 2021, time=2021-01-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2102408, encodeId=5abd2102408f9, content=想问一下 author consent 怎么写呀没有在官网上找到模板, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/ibHKLVerWUC6yA015Ulu0FMP25mVc8zpF2pTqqibxmn0mD6oiblRHRJicmK18IZjr8cP1ZwLAclpASA2ib1iboqnBjnQ/132, createdBy=deed2538978, createdName=2668, createdTime=Thu Nov 24 14:28:22 CST 2022, time=2022-11-24, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=904198, encodeId=2d8390419824, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：内分泌 经验分享：感觉这个杂志还蛮友好的，9月初投的，20天后修回，大修俩月，提交后7天内接收，，，速度很快了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=223, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cae35440569, createdName=雨的印记373, createdTime=Wed Dec 02 10:47:43 CST 2020, time=2020-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2107104, encodeId=2894210e104f8, content=这篇杂志怎么选择OA啊，投稿系统里好像没找到, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230207/b5a05d43ae3d4607be87681842f23191/2d0014efa1884564aaf3c599d3ce0930.jpg, createdBy=3e988123090, createdName=ms8000000110142808, createdTime=Thu Dec 22 21:47:52 CST 2022, time=2022-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1237426, encodeId=ae9d123e4263a, content=已经decision in process一个半月了，还没结果，邮件也不回, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ed76523841, createdName=ms8000000952576819, createdTime=Mon Aug 08 19:01:25 CST 2022, time=2022-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=545734, encodeId=5595545e34dd, content=投的meta，审稿很慢，5个多月，还是被拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=424, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7cb81934323, createdName=zxyy1386, createdTime=Mon Aug 21 15:57:00 CST 2017, time=2017-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092943, encodeId=fcd3109294324, content=结果中的重要文献是在结果体现，还是在引言中描述？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092944, encodeId=a7e7109294482, content=方法的撰写顺序/逻辑顺序是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=)]

2022-12-22 ms8000000110142808

这篇杂志怎么选择OA啊，投稿系统里好像没找到

105 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2160645, encodeId=6e462160645b6, content=找了一天作者协议，还是没找到😓, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e99e8999472, createdName=ms7000001592099357, createdTime=Mon Oct 02 19:40:44 CST 2023, time=2023-10-02, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2139436, encodeId=836e213943670, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：投的meta，审稿非常快，编辑光速送审，5月7号送审，24号给了major revision，两个审稿人，一个很客气，说文章写的很好没有意见，另一个让补充一些方法学上的细节。好好修改感觉希望挺大，加油。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9e446571671, createdName=ms4000000706495698, createdTime=Sat May 27 22:31:56 CST 2023, time=2023-05-27, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=921068, encodeId=d6e692106875, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：1.8号投稿，29号小修回来，这个杂志还挺友善！我的第一篇英文顺利的不敢相信, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=191, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1ca92518561, createdName=124d4ad8m98暂无昵称, createdTime=Fri Jan 29 16:00:11 CST 2021, time=2021-01-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2102408, encodeId=5abd2102408f9, content=想问一下 author consent 怎么写呀没有在官网上找到模板, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/ibHKLVerWUC6yA015Ulu0FMP25mVc8zpF2pTqqibxmn0mD6oiblRHRJicmK18IZjr8cP1ZwLAclpASA2ib1iboqnBjnQ/132, createdBy=deed2538978, createdName=2668, createdTime=Thu Nov 24 14:28:22 CST 2022, time=2022-11-24, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=904198, encodeId=2d8390419824, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：内分泌 经验分享：感觉这个杂志还蛮友好的，9月初投的，20天后修回，大修俩月，提交后7天内接收，，，速度很快了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=223, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cae35440569, createdName=雨的印记373, createdTime=Wed Dec 02 10:47:43 CST 2020, time=2020-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2107104, encodeId=2894210e104f8, content=这篇杂志怎么选择OA啊，投稿系统里好像没找到, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230207/b5a05d43ae3d4607be87681842f23191/2d0014efa1884564aaf3c599d3ce0930.jpg, createdBy=3e988123090, createdName=ms8000000110142808, createdTime=Thu Dec 22 21:47:52 CST 2022, time=2022-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1237426, encodeId=ae9d123e4263a, content=已经decision in process一个半月了，还没结果，邮件也不回, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ed76523841, createdName=ms8000000952576819, createdTime=Mon Aug 08 19:01:25 CST 2022, time=2022-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=545734, encodeId=5595545e34dd, content=投的meta，审稿很慢，5个多月，还是被拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=424, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7cb81934323, createdName=zxyy1386, createdTime=Mon Aug 21 15:57:00 CST 2017, time=2017-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092943, encodeId=fcd3109294324, content=结果中的重要文献是在结果体现，还是在引言中描述？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092944, encodeId=a7e7109294482, content=方法的撰写顺序/逻辑顺序是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=)]

2022-08-08 ms8000000952576819

已经decision in process一个半月了，还没结果，邮件也不回

101 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2160645, encodeId=6e462160645b6, content=找了一天作者协议，还是没找到😓, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e99e8999472, createdName=ms7000001592099357, createdTime=Mon Oct 02 19:40:44 CST 2023, time=2023-10-02, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2139436, encodeId=836e213943670, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：投的meta，审稿非常快，编辑光速送审，5月7号送审，24号给了major revision，两个审稿人，一个很客气，说文章写的很好没有意见，另一个让补充一些方法学上的细节。好好修改感觉希望挺大，加油。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9e446571671, createdName=ms4000000706495698, createdTime=Sat May 27 22:31:56 CST 2023, time=2023-05-27, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=921068, encodeId=d6e692106875, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：1.8号投稿，29号小修回来，这个杂志还挺友善！我的第一篇英文顺利的不敢相信, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=191, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1ca92518561, createdName=124d4ad8m98暂无昵称, createdTime=Fri Jan 29 16:00:11 CST 2021, time=2021-01-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2102408, encodeId=5abd2102408f9, content=想问一下 author consent 怎么写呀没有在官网上找到模板, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/ibHKLVerWUC6yA015Ulu0FMP25mVc8zpF2pTqqibxmn0mD6oiblRHRJicmK18IZjr8cP1ZwLAclpASA2ib1iboqnBjnQ/132, createdBy=deed2538978, createdName=2668, createdTime=Thu Nov 24 14:28:22 CST 2022, time=2022-11-24, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=904198, encodeId=2d8390419824, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：内分泌 经验分享：感觉这个杂志还蛮友好的，9月初投的，20天后修回，大修俩月，提交后7天内接收，，，速度很快了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=223, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cae35440569, createdName=雨的印记373, createdTime=Wed Dec 02 10:47:43 CST 2020, time=2020-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2107104, encodeId=2894210e104f8, content=这篇杂志怎么选择OA啊，投稿系统里好像没找到, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230207/b5a05d43ae3d4607be87681842f23191/2d0014efa1884564aaf3c599d3ce0930.jpg, createdBy=3e988123090, createdName=ms8000000110142808, createdTime=Thu Dec 22 21:47:52 CST 2022, time=2022-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1237426, encodeId=ae9d123e4263a, content=已经decision in process一个半月了，还没结果，邮件也不回, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ed76523841, createdName=ms8000000952576819, createdTime=Mon Aug 08 19:01:25 CST 2022, time=2022-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=545734, encodeId=5595545e34dd, content=投的meta，审稿很慢，5个多月，还是被拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=424, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7cb81934323, createdName=zxyy1386, createdTime=Mon Aug 21 15:57:00 CST 2017, time=2017-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092943, encodeId=fcd3109294324, content=结果中的重要文献是在结果体现，还是在引言中描述？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092944, encodeId=a7e7109294482, content=方法的撰写顺序/逻辑顺序是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=)]

2017-08-21 zxyy1386

投的meta，审稿很慢，5个多月，还是被拒了

424 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2160645, encodeId=6e462160645b6, content=找了一天作者协议，还是没找到😓, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e99e8999472, createdName=ms7000001592099357, createdTime=Mon Oct 02 19:40:44 CST 2023, time=2023-10-02, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2139436, encodeId=836e213943670, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：投的meta，审稿非常快，编辑光速送审，5月7号送审，24号给了major revision，两个审稿人，一个很客气，说文章写的很好没有意见，另一个让补充一些方法学上的细节。好好修改感觉希望挺大，加油。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9e446571671, createdName=ms4000000706495698, createdTime=Sat May 27 22:31:56 CST 2023, time=2023-05-27, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=921068, encodeId=d6e692106875, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：1.8号投稿，29号小修回来，这个杂志还挺友善！我的第一篇英文顺利的不敢相信, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=191, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1ca92518561, createdName=124d4ad8m98暂无昵称, createdTime=Fri Jan 29 16:00:11 CST 2021, time=2021-01-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2102408, encodeId=5abd2102408f9, content=想问一下 author consent 怎么写呀没有在官网上找到模板, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/ibHKLVerWUC6yA015Ulu0FMP25mVc8zpF2pTqqibxmn0mD6oiblRHRJicmK18IZjr8cP1ZwLAclpASA2ib1iboqnBjnQ/132, createdBy=deed2538978, createdName=2668, createdTime=Thu Nov 24 14:28:22 CST 2022, time=2022-11-24, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=904198, encodeId=2d8390419824, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：内分泌 经验分享：感觉这个杂志还蛮友好的，9月初投的，20天后修回，大修俩月，提交后7天内接收，，，速度很快了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=223, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cae35440569, createdName=雨的印记373, createdTime=Wed Dec 02 10:47:43 CST 2020, time=2020-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2107104, encodeId=2894210e104f8, content=这篇杂志怎么选择OA啊，投稿系统里好像没找到, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230207/b5a05d43ae3d4607be87681842f23191/2d0014efa1884564aaf3c599d3ce0930.jpg, createdBy=3e988123090, createdName=ms8000000110142808, createdTime=Thu Dec 22 21:47:52 CST 2022, time=2022-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1237426, encodeId=ae9d123e4263a, content=已经decision in process一个半月了，还没结果，邮件也不回, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ed76523841, createdName=ms8000000952576819, createdTime=Mon Aug 08 19:01:25 CST 2022, time=2022-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=545734, encodeId=5595545e34dd, content=投的meta，审稿很慢，5个多月，还是被拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=424, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7cb81934323, createdName=zxyy1386, createdTime=Mon Aug 21 15:57:00 CST 2017, time=2017-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092943, encodeId=fcd3109294324, content=结果中的重要文献是在结果体现，还是在引言中描述？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092944, encodeId=a7e7109294482, content=方法的撰写顺序/逻辑顺序是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=)]

2021-12-28 Mia

结果中的重要文献是在结果体现，还是在引言中描述？

110 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2160645, encodeId=6e462160645b6, content=找了一天作者协议，还是没找到😓, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e99e8999472, createdName=ms7000001592099357, createdTime=Mon Oct 02 19:40:44 CST 2023, time=2023-10-02, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2139436, encodeId=836e213943670, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：投的meta，审稿非常快，编辑光速送审，5月7号送审，24号给了major revision，两个审稿人，一个很客气，说文章写的很好没有意见，另一个让补充一些方法学上的细节。好好修改感觉希望挺大，加油。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9e446571671, createdName=ms4000000706495698, createdTime=Sat May 27 22:31:56 CST 2023, time=2023-05-27, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=921068, encodeId=d6e692106875, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：1.8号投稿，29号小修回来，这个杂志还挺友善！我的第一篇英文顺利的不敢相信, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=191, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1ca92518561, createdName=124d4ad8m98暂无昵称, createdTime=Fri Jan 29 16:00:11 CST 2021, time=2021-01-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2102408, encodeId=5abd2102408f9, content=想问一下 author consent 怎么写呀没有在官网上找到模板, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/ibHKLVerWUC6yA015Ulu0FMP25mVc8zpF2pTqqibxmn0mD6oiblRHRJicmK18IZjr8cP1ZwLAclpASA2ib1iboqnBjnQ/132, createdBy=deed2538978, createdName=2668, createdTime=Thu Nov 24 14:28:22 CST 2022, time=2022-11-24, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=904198, encodeId=2d8390419824, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：内分泌 经验分享：感觉这个杂志还蛮友好的，9月初投的，20天后修回，大修俩月，提交后7天内接收，，，速度很快了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=223, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cae35440569, createdName=雨的印记373, createdTime=Wed Dec 02 10:47:43 CST 2020, time=2020-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2107104, encodeId=2894210e104f8, content=这篇杂志怎么选择OA啊，投稿系统里好像没找到, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230207/b5a05d43ae3d4607be87681842f23191/2d0014efa1884564aaf3c599d3ce0930.jpg, createdBy=3e988123090, createdName=ms8000000110142808, createdTime=Thu Dec 22 21:47:52 CST 2022, time=2022-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1237426, encodeId=ae9d123e4263a, content=已经decision in process一个半月了，还没结果，邮件也不回, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ed76523841, createdName=ms8000000952576819, createdTime=Mon Aug 08 19:01:25 CST 2022, time=2022-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=545734, encodeId=5595545e34dd, content=投的meta，审稿很慢，5个多月，还是被拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=424, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7cb81934323, createdName=zxyy1386, createdTime=Mon Aug 21 15:57:00 CST 2017, time=2017-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092943, encodeId=fcd3109294324, content=结果中的重要文献是在结果体现，还是在引言中描述？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092944, encodeId=a7e7109294482, content=方法的撰写顺序/逻辑顺序是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=)]

2021-12-27 Gym璨烨

方法的撰写顺序/逻辑顺序是什么？

122 1

展开1条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务